← Back

Wire · regulatory

Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487 ...

Published

7 August 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at cms.gov →

◆ Verified

Fusion42 · 8 August 2026 · Fusion42 review

CMS and FDA propose the RAPID coverage pathway to accelerate Medicare coverage for eligible FDA-designated Breakthrough medical devices, enabling Medicare coverage decisions within 60 to 90 days of FDA market authorisation through aligned evidence requirements and early engagement with manufacturers.

This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 7 Aug 2026 and 12 Aug 2026.

◆ ◆ The Wire takeaway

You now gain a clear, faster route to Medicare coverage if you develop breakthrough medical devices. Engage with both FDA and CMS early to align your clinical studies with Medicare outcomes and enter the market faster with predictable reimbursement timelines.

◆ Coverage

4 sources · first reported 7 Aug 2026 · latest 12 Aug 2026

◆ Related on Wire

◆ Topics

Medtechmedicarefdadevice-coveragebreakthrough-devicesregulatory-alignment